Enhance indoor health: Improve environmental quality for better living
While many people focus on airborne contaminants, it's equally important to consider other factors that affect IEQ. Dust, allergens, germs, and odors from dirty furniture, carpets, and unclean AC units can compromise indoor air quality. Neglected furniture can trigger skin allergies and respiratory issues, while unclean AC systems circulate musty odors, dust, bacteria, and mold spores, creating an unhealthy environment.
The Healthy Home® is on a mission to help improve Indoor Environmental Quality by offering comprehensive home wellness solutions like home deep cleaning, AC cleaning, and furniture cleaning, to sanitisation, mold removal, and IEQ testing to ensure a healthier living space. With over a decade of experience, they have served 61,000+ satisfied customers across the UAE, Saudi Arabia, and Kuwait, with a 4.9/5 rating on Google from 7,000+ reviews.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Business
an hour ago
- Gulf Business
WHX Tech: The next frontier in healthcare innovation
Image credit: WHX Tech/Website In a bold move that underscores the Middle East's growing leadership in digital health, Read- Held under the patronage of the UAE Ministry of Health and Prevention, Dubai Health Authority, Dubai Health, Emirates Health Services and in partnership with HIMSS, the inaugural WHX Tech event brings together healthcare leaders, tech innovators and investors to tackle the biggest challenges and shape the future of healthcare. Redefining the future of healthcare As healthcare systems worldwide contend with aging populations, rising costs, and increasing demand for personalised care, digital technologies are playing a critical role in shaping the future. WHX Tech is designed to respond directly to these challenges, providing a dedicated platform to explore the latest in artificial intelligence, robotics, remote care, and health data interoperability. According to Solenne Singer, Vice President – Healthcare at Informa Markets, the creation of WHX Tech is a strategic response to global demand for innovation hubs that accelerate the adoption of digital health solutions. 'Dubai offers a unique combination of forward-thinking regulation, smart infrastructure, and regional influence. It's the perfect launchpad for this next-generation event,' Singer said. Global gathering for tech trailblazers WHX Tech is expected to attract over 5,000 digital health professionals, over 300 brands, and 200+ speakers, creating a melting pot of ideas and innovations. From healthcare providers and investors to entrepreneurs and government leaders, the event is poised to drive cross-sector collaboration. WHX tech agenda Attendees can explore a dynamic lineup of panels, live demonstrations, and thought-provoking fireside chats that are set to redefine digital healthcare. From pioneering advancements like AI-driven smart hospitals and space-based medicine to delivering digital health solutions to displaced populations, Participants are encouraged to discover what's in store and begin planning their visit. Three stages, one vision The conference programme at WHX Tech is structured around three dynamic stages, each focused on a unique aspect of healthcare transformation: World X – Global Perspectives on Digital Health Innovation Across three immersive days, World X offers a deep dive into how nations around the globe are embracing digital health at scale. Attendees will explore real-world case studies showcasing the implementation of cutting-edge technologies, including artificial intelligence, diagnostics, remote monitoring, and digital therapeutics. The event provides a rare opportunity to understand how innovations such as robotics, virtual care, and data analytics are actively transforming modern healthcare systems, driving efficiency, equity, and improved patient outcomes. Xcelerate – Catalysing the next generation of health tech leaders Xcelerate brings participants into the heart of the investment conversation, offering a front-row seat to how venture capitalists and angel investors identify the next wave of health tech disruptors. Industry leaders share firsthand insights into what fuels their investment decisions—what sparks interest, what raises red flags, and what convinces them to commit. The stage features the Xcelerate startup pitch competition, as emerging companies compete for a $50,000 equity-free cash prize. It's a rare chance to witness the decision-making process behind the rise of tomorrow's healthcare unicorns, and to gain invaluable insider knowledge on market trends, investor priorities, and innovation trajectories. Future X – Showcasing the frontier of healthcare technology At Future X, the boundary between science fiction and clinical reality continues to blur. This showcase is a launchpad for the most visionary technologies reshaping the future of care—from AI and robotics to quantum computing. Through live demonstrations and product unveilings, innovators from around the world present breakthroughs that are already influencing patient care. It's more than a glimpse of what's next; it's a firsthand experience of how transformative technologies are being built and implemented in real-time, redefining the future of global health. Backed by global experts A key differentiator for WHX Tech is its advisory board, comprising world-renowned digital health experts who ensure the programming remains cutting-edge and globally relevant. Confirmed members include: Dr. David Rhew, global chief medical officer & VP of Healthcare, Microsoft Dr. Sam Shah, director of Healthcare Data Management, NEOM Reenita Das, partner and senior VP, Healthcare and Life Sciences, Frost & Sullivan Dr. Myriam Fernandez, Head of Health Innovation, AWS Dr. James Mault, CEO, BioIntelliSense Their collective insights shape a programme rooted in evidence, scalability, and impact. Meet the health experts who will shape the future of healthcare at WHX Tech: Dr. Avi Mehra – Associate Partner, IBM Healthcare & Life Sciences Dr. Justus Wolff – EU Focus Group on AI Implementation Zayna Khayat, Applied Health Futurist Dr. Devi Shetty – Founder & Chairman, Narayana Health Khulood Mohamed Alsayegh – Head of Clinical Standards and Guidelines Section Health Policies and Standard Department, DHA Dr. Mohammad Al Redha – Director, Health Informatics & Smart Health, DHA Mahesh Alpannan – Head of Digital Health, MOH Malaysia Araceli Camacho – Transformation Director, Hospital Clinic Barcelona These speakers, among others, will address emerging digital health trends, health equity, policy evolution, investment strategies, and entrepreneurial resilience. Strategic alignment with national and global priorities WHX Tech aligns with the UAE's National AI Strategy 2031, the World Health Organization's digital health objectives, and broader efforts toward universal health coverage. By convening decision-makers across tech, healthcare, and policy, the event supports regional and international health agendas. Why attend? With a full spectrum of digital health sectors represented, WHX Tech offers unmatched access to trends, partnerships, and market opportunities. Attendees will benefit from: Curated networking via the Connections Programme, which facilitates 1:1 meetings between buyers and solution providers. An exclusive Investors Programme, giving access to high-growth startups and early-stage deal flow. Presentations from over 200 expert speakers and thought leaders. An event unlike any other Unlike traditional health expos, WHX Tech is purpose-built to drive real-world outcomes. It's more than just a showcase; it's a launchpad for solutions and a meeting point for visionaries looking to transform care models, improve patient experiences, and shape the future of digital health. Whether you are a policymaker, technologist, healthcare provider, or investor, WHX Tech 2025 offers a front-row seat to the most transformative health innovations of our time.
Emirates 24/7
2 hours ago
- Emirates 24/7
UAE extends lifeline to Gaza's health sector, averting total collapse
The UAE, through its humanitarian efforts and relief aid under Operation Chivalrous Knight 3, has managed to keep the Gaza Strip's health sector operational, averting total collapse and ensuring continued medical services for the Palestinian people. The UAE demonstrated utmost readiness and high professionalism during its swift intervention to address the escalating medical challenges in the Gaza Strip. This was evident through its presence on the ground via the Emirati field hospital inside the Strip, the floating hospital deployed to Egypt's Al Arish city, the transfer of critical and severe cases to UAE hospitals for treatment, and the dispatch of various medical aid and supplies to enhance Gaza's health sector capabilities. Since its inauguration in December 2023, the Emirati integrated field hospital in Gaza has continued to provide treatment services to the people of Gaza through specialised and qualified cadres in various medical fields, supported by medical volunteers. By April 2025, the number of cases treated at the hospital exceeded 51,000, including critical injuries and complex surgical operations. Through the hospital, the UAE launched a humanitarian initiative to provide prosthetics for injured individuals who underwent amputations, aiming to support their rehabilitation and help them regain their normal lives. The facility has a capacity of 200 beds and includes operating rooms equipped for various types of surgeries. The medical team successfully removed a 5-kilogramme tumour from the abdomen of a patient who had endured years of severe pain and complications. In February 2024, the UAE dispatched an integrated floating hospital off the coast of Al Arish to provide medical support to Palestinians. The facility includes a medical and administrative team across various specialties, such as anaesthesiology, general surgery, orthopaedics, and emergency medicine. By April 2025, the hospital had treated approximately 10,370 cases. It has a capacity of 100 beds, operating rooms, intensive care units, radiology, a laboratory, a pharmacy, and medical warehouses. In addition to on-the-ground support, the UAE has also facilitated the transfer of critical patients to its hospitals. Under the directives of President His Highness Sheikh Mohamed bin Zayed Al Nahyan, the UAE committed to hosting 1,000 Palestinian cancer patients of all ages, as well as 1,000 Palestinian children with their families, to ensure they receive complete healthcare until they can return home. By 14th May, a total of 2,634 patients and family members had arrived in the UAE, demonstrating the country's commitment to providing necessary treatment. Medical and health supplies constitute a significant part of the total humanitarian aid the UAE continues to deliver to Gaza since the beginning of the crisis. These include various types of medicines and equipment, such as dialysis machines, ultrasound devices, lung resuscitation devices, wheelchairs, artificial respiration masks, and ambulances. After 500 days since the launch of Operation Chivalrous Knight 3, the UAE has provided more than 1,200 tonnes of medical materials and supplies to support Gaza's hospitals. The health system was further reinforced with 17 ambulances equipped with the latest technology. A comprehensive polio vaccination campaign was also implemented, covering over 640,000 children as part of preventive efforts to protect future generations from infectious diseases. Between 1st January and 24th April 2025, Dubai Humanitarian sent three relief shipments to Al Arish International Airport in support of Gaza, carrying approximately 256 metric tonnes of medical supplies belonging to the World Health Organisation. To enhance public health and prevent communicable diseases, the UAE also contributes through projects and initiatives that provide safe drinking water in the Gaza Strip and implements measures to repair sewage networks, aiming to reduce pollution and curb the spread of epidemics and infectious diseases.
Gulf Business
2 hours ago
- Gulf Business
UAE sets new standards for next-generation oral products
Credit: Getty Images In this interview, Alexandre Ghanem, Cluster Head of Middle East & North Africa (MENA) at BAT, discusses the significance of the new rules, how they align with global harm reduction efforts, and BAT's plans to launch a new portfolio in the UAE. Pictured: Alexandre Ghanem, Cluster Head of Middle East & North Africa (MENA) at BAT. What are BAT's plans for the UAE with this new regulatory framework in mind? The UAE's decision to issue regulatory requirements for tobacco-free oral nicotine pouches aligns with BAT's transformation and our vision of creating 'A Better Tomorrow'—a smokeless world driven by reducing the health impact of our business. Tobacco Harm Reduction (THR) as a policy encourages adult consumers who would otherwise continue to smoke to switch to lower-risk alternatives. Adult smokers and nicotine users in the UAE are progressive and open to innovative products. The UAE standard now provides access to high-quality alternatives, which is why BAT plans to introduce a new portfolio of tobacco-free oral nicotine pouches under the VELO brand in the market, in line with our THR ambitions. How significant is regulating tobacco-free oral nicotine pouches to harm reduction in the UAE? The UAE continues to lead in regulatory innovation. The Ministry of Industry and Advanced Technology's (MoIAT) decision to issue a technical standard for tobacco-free oral nicotine pouches reflects a strong commitment to public health and quality control. It is widely accepted that most harm from smoking comes from inhaling the smoke produced by burning tobacco—not from nicotine itself. Tobacco-free oral nicotine pouches, being smokeless and tobacco-free, present a reduced-risk profile when compared to combustible products, assuming a complete switch from smoking. How effective has the launch of BAT's tobacco-free nicotine pouches been elsewhere? Can that success be replicated in the UAE? Our tobacco-free nicotine pouches are currently available in over 40 countries, with 7.4 million adult consumers globally. VELO products are developed under rigorous stewardship and have been shown to contain 90–99 per cent fewer toxic chemicals compared to cigarette smoke. The broader category of oral nicotine pouches has contributed significantly to global public health by reducing smoking rates. Sweden is a notable example, where oral nicotine has largely replaced smoking over the past 70 years, resulting in the lowest smoking rate and lung cancer mortality rate in Europe—29.1 deaths per 100,000 compared to the EU average of 66.7 (2020 data). As of 2024, Sweden's smoking rate stands at 5.3 per cent, positioning it to achieve the WHO's 'smoke-free' status and putting the country 15 years ahead of the EU's 2040 target. Where do tobacco-free oral nicotine pouches fall on the risk continuum compared to cigarettes? Leading health bodies, including the US FDA, acknowledge that the main causes of smoking-related diseases are the harmful chemicals in tobacco smoke—not nicotine itself. In 2008, the WHO identified nine key toxicants in cigarette smoke. In VELO products, these are reduced by more than 99 per cent. While smokers may be addicted to nicotine, nicotine itself is not classified as a carcinogen. The Royal College of Physicians in London reinforces this, noting that the real danger lies in the smoke. If nicotine can be delivered in an effective and acceptable smokeless form, such as oral pouches, most—if not all—of the harm from smoking could potentially be avoided.
